Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $402 - $449
4 Added 0.11%
3,596 $374,000
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $276,318 - $305,182
-2,523 Reduced 41.26%
3,592 $408,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $1,050 - $1,260
11 Added 0.18%
6,115 $592,000
Q2 2023

Aug 25, 2023

BUY
$100.78 - $112.29 $1,713 - $1,908
17 Added 0.28%
6,104 $665,000
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $1,549 - $1,824
-16 Reduced 0.26%
6,087 $616,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $7,985 - $9,367
-84 Reduced 1.36%
6,103 $670,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $19,545 - $22,630
-202 Reduced 3.16%
6,187 $599,000
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $4,695 - $5,675
46 Added 0.73%
6,389 $694,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $9,691 - $11,818
85 Added 1.36%
6,343 $750,000
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $1,039 - $1,273
-9 Reduced 0.14%
6,258 $881,000
Q3 2021

Nov 05, 2021

SELL
$116.66 - $129.06 $81,195 - $89,825
-696 Reduced 10.0%
6,267 $740,000
Q2 2021

Aug 17, 2021

SELL
$105.79 - $124.53 $736,615 - $867,102
-6,963 Reduced 50.0%
6,963 $834,000
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $791,157 - $932,103
7,269 Added 109.19%
13,926 $1.67 Million
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $17,850 - $19,451
-170 Reduced 2.49%
6,657 $729,000
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $6,414 - $7,790
-70 Reduced 1.01%
6,827 $743,000
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $27,718 - $35,476
-362 Reduced 4.99%
6,897 $631,000
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $10,239 - $14,973
163 Added 2.3%
7,259 $573,000
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $41,060 - $45,710
523 Added 7.96%
7,096 $616,000
Q3 2019

Nov 12, 2019

SELL
$81.84 - $88.74 $900 - $976
-11 Reduced 0.17%
6,573 $550,000
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $8,381 - $9,775
-115 Reduced 1.72%
6,584 $554,000
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $31,719 - $38,348
-479 Reduced 6.67%
6,699 $535,000
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $14,095 - $15,968
215 Added 3.09%
7,178 $519,000
Q3 2018

Nov 15, 2018

SELL
$60.81 - $73.36 $9,364 - $11,297
-154 Reduced 2.16%
6,963 $511,000
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $30,281 - $33,422
-526 Reduced 6.88%
7,117 $434,000
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $1,125 - $1,272
-20 Reduced 0.26%
7,643 $458,000
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $67,314 - $72,067
-1,254 Reduced 14.06%
7,663 $437,000
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $35,035 - $39,103
-729 Reduced 7.56%
8,917 $476,000
Q2 2017

Aug 14, 2017

BUY
N/A
9,646
9,646 $469,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Eubel Brady & Suttman Asset Management Inc Portfolio

Follow Eubel Brady & Suttman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eubel Brady & Suttman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eubel Brady & Suttman Asset Management Inc with notifications on news.